Phase 2a trial

LUND, Sweden, May 27, 2026 Hansa Biopharma AB has announced positive topline results from its European Post Authorization Efficacy...

BOSTON, May 27, 2026 TransCode Therapeutics, Inc., a clinical-stage biotechnology company focused on RNA-based cancer therapeutics, has announced the...

NEW YORK, United States – May 5, 2026 Hoth Therapeutics, Inc. has announced that it secured regulatory authorization in...

BASEL, Switzerland and BOSTON, MA, May 1, 2026 Noema Pharma AG announced the presentation of positive Phase 2a clinical...

PALO ALTO, Calif. & NEW YORK, Feb. 10, 2026 — Clinical-stage biotechnology company Evommune announced positive top-line results from...

December 22, 2025 | Juno Beach, Florida — Aqualung Therapeutics announced that the U.S. Food and Drug Administration (FDA)...